大流行期间医疗负担与能力变化与非COVID-19患者临床结局的关联:多中心回顾性队列研究
该多中心回顾性队列纳入日本23个ICU中2019年1月至2023年2月收治的非COVID-19患者,通过2023年11月问卷将ICU分为能力受限组(评分高于中位数,9个ICU,25568例)与能力维持组(14个ICU,45068例)。主要结局为以APACHE III-j模型计算的标准化死亡比(SMR)与疫情前水平比较:能力受限组在四波疫情中SMR升高,能力维持组仅在一波中升高。采用广义线性泊松混合效应模型(含offset时间项)调整后,能力受限(HR 1.19,95%CI 1.01-1.41,p=0.04)和重症COVID-19患者数(每5例,HR 1.09,95%CI 1.03-1.16,p=0.002)与院内死亡相关,而ICU床位占用率无关联。作者强调需主动策略减轻医疗负担和能力限制以应对未来准备。
要点
- 能力受限组(9个ICU,25568例)在四波疫情中SMR升高,能力维持组(14个ICU,45068例)仅一波SMR升高。
- 调整后能力受限与院内死亡相关:HR 1.19(95%CI 1.01-1.41,p=0.04)。
- 重症COVID-19患者数每增加5例,院内死亡HR 1.09(95%CI 1.03-1.16,p=0.002)。
- ICU床位占用率与院内死亡无关联。
- 作者认为需主动策略减轻医疗负担和能力限制以应对未来准备。
适用人群与场景
- 日本23个ICU中2019年1月至2023年2月收治的非COVID-19患者。
诊断标准与关键阈值
- 2023年11月完成基于网络的医疗负担与能力限制问卷,评分超过中位数的ICU分类为能力受限,否则为能力维持。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究,23个ICU(日本),非COVID-19患者;能力受限组9个ICU共25568例,能力维持组14个ICU共45068例。
- 主要结局:以APACHE III-j模型计算的标准化死亡比(SMR)与疫情前水平比较;能力受限组在四波疫情中SMR升高,能力维持组仅在一波中升高。
- 调整后能力受限与院内死亡相关:HR 1.19(95%CI 1.01-1.41,p=0.04)。
- 调整后重症COVID-19患者数(每5例)与院内死亡相关:HR 1.09(95%CI 1.03-1.16,p=0.002)。
- 调整后ICU床位占用率与院内死亡无关联。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需主动策略减轻医疗负担和能力限制以应对未来准备。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The spillover impact of the COVID-19 pandemic on patients without COVID-19 in ICUs should be assessed. We aimed to assess the association of ICUs' medical burden and capacity changes with clinical outcomes in such patients during the COVID-19 pandemic.
DESIGN: Retrospective cohort study.
SETTING: Twenty-three ICUs in Japan.
PATIENTS: Patients without COVID-19 in ICUs from January 2019 to February 2023.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: These ICUs completed a web-based questionnaire on medical burden and capacity limitations in November 2023, and they were classified as having a limited capacity if their scores exceeded the median; otherwise, they were categorized as having a maintained capacity. The primary outcome was the standardized mortality ratio (SMR), calculated with the Acute Physiology and Chronic Health Evaluation III-j model, compared with the pre-pandemic level. Using individual-level patient data, a generalized linear Poisson mixed-effects model including an offset-time term was employed to assess the association of capacity limitation, the number of patients with COVID-19, and ICU bed occupancy on the day of admission, with hazard ratios for in-hospital death. Nine and fourteen ICUs had a limited capacity (25,568 patients) and a maintained capacity (45,068 patients), respectively. SMRs increased in four epidemic waves in the ICUs with a limited capacity but in only one wave in those with a maintained capacity. After adjustment, capacity limitation (hazard ratio, 1.19; 95% CI, 1.01-1.41; p = 0.04) and the number of patients with severe COVID-19 (per five patients; hazard ratio, 1.09; 95% CI, 1.03-1.16; p = 0.002) were associated with in-hospital mortality, but ICU bed occupancy was not.
CONCLUSIONS: SMRs increased more frequently in ICUs with a limited capacity during the pandemic. Our findings emphasize the need for proactive strategies to mitigate medical burden and capacity limitations for future preparedness.
参考来源
- Sakuraya M, Sugimoto T, Kikutani K, et al. Association of Medical Burden and Capacity Changes With Clinical Outcomes Among Patients Without COVID-19 During the Pandemic: A Multicenter Retrospective Cohort Study. Crit Care Med. 2025. PMID: 40693840. doi:10.1097/CCM.0000000000006785
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。